Q2 2017 13F Holders as of 6/30/2017
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
170M
-
Number of holders
-
70
-
Total 13F shares, excl. options
-
28.1M
-
Shares change
-
-402K
-
Total reported value, excl. options
-
$318M
-
Value change
-
-$4.53M
-
Put/Call ratio
-
0.31
-
Number of buys
-
33
-
Number of sells
-
-34
-
Price
-
$11.30
Significant Holders of Seres Therapeutics, Inc. - COMMON STOCK (MCRB) as of Q2 2017
86 filings reported holding MCRB - Seres Therapeutics, Inc. - COMMON STOCK as of Q2 2017.
Seres Therapeutics, Inc. - COMMON STOCK (MCRB) has 70 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 28.1M shares
of 170M outstanding shares and own 16.52% of the company stock.
Largest 10 shareholders include Flagship Pioneering Inc. (12.7M shares), FMR LLC (6.06M shares), VANGUARD GROUP INC (1.59M shares), Capital World Investors (1.56M shares), ARK Investment Management LLC (765K shares), FEDERATED INVESTORS INC /PA/ (749K shares), Artal Group S.A. (600K shares), D. E. Shaw & Co., Inc. (527K shares), PRICE T ROWE ASSOCIATES INC /MD/ (464K shares), and RENAISSANCE TECHNOLOGIES LLC (460K shares).
This table shows the top 70 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.